Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy

NCT06268613

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • SB Investigative Site Gdansk, Poland
  • SB Investigative Site Otwock, Poland
  • SB Investigative Site Ansan, South Korea
  • SB Investigative Site Busan, South Korea
View all 24 locations
View Trial Details
Active, Not Recruiting

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

NCT01888601

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Princess Alexandra Hospital NHS Trust Harlow, Essex, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • University College London Hospitals NHS Foundation Trust London, Select Region, United Kingdom
  • Ashford and St Peter's Hospitals NHS Foundation Trust Chertsey, Surrey, United Kingdom
View all 18 locations
View Trial Details
Active, Not Recruiting

NADIM II: Neo-Adjuvant Immunotherapy

NCT03838159

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital General de Alicante Alicante, Spain
  • ICO Badalona Badalona, Barcelona, Spain
  • Hospital Universitari Dexeus Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 25 locations
View Trial Details
Active, Not Recruiting

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

NCT02486718

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
  • Compassionate Cancer Care Medical Group, Inc Fountain Valley, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 154 locations
View Trial Details
Active, Not Recruiting

Osimertinib In EGFR Mutant Lung Cancer

NCT03586453

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions